Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia

NCT01226303 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Acute Promyelocytic Leukemia

Interventions

DRUG: ATRA
DRUG: ATRA + IDA

Sponsor

Associazione Italiana Ematologia Oncologia Pediatrica